<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Baby KJ: World's First Personalized CRISPR Therapy Success | News That's Not Crap</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
    <style>
        :root {
            --wgac-brown: #a1512e;
            --wgac-green-light: #d7f6a4;
            --wgac-blue: #4368ff;
            --wgac-teal: #2dcb98;
            --wgac-coral: #e85d4c;
            --wgac-yellow: #f0c808;
            --wgac-purple: #7b68ee;
            --wgac-pink: #e84393;
            --cream: #faf9f6;
            --dark: #1a1a1a;
            --gray-100: #f5f4f2;
            --gray-200: #e8e6e3;
            --gray-400: #a09d98;
            --gray-600: #6b6761;
            --font-display: 'Instrument Serif', Georgia, serif;
            --font-body: 'IBM Plex Sans', -apple-system, BlinkMacSystemFont, sans-serif;
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }

        body {
            font-family: var(--font-body);
            background: var(--cream);
            color: var(--dark);
            line-height: 1.6;
            -webkit-font-smoothing: antialiased;
        }

        a { color: inherit; text-decoration: none; }

        /* Header */
        .site-header {
            background: var(--dark);
            padding: 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }

        .header-top {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 1.25rem 3rem;
            border-bottom: 1px solid rgba(255,255,255,0.1);
        }

        .logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 1rem;
            font-weight: 800;
            text-decoration: none;
        }

        .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .header-date {
            color: var(--gray-400);
            font-size: 0.8rem;
            font-weight: 500;
            letter-spacing: 0.5px;
            text-transform: uppercase;
        }

        /* Navigation */
        .main-nav {
            display: flex;
            justify-content: center;
            gap: 2px;
            padding: 0.75rem 0;
            background: var(--dark);
        }

        .nav-link {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 0.5px;
            text-transform: uppercase;
            padding: 0.5rem 1rem;
            transition: all 0.15s ease;
            background: rgba(255,255,255,0.1);
            color: white;
        }

        .nav-link:hover {
            background: white;
            color: var(--dark);
        }

        .nav-link.active {
            background: var(--wgac-blue);
            color: white;
        }

        /* Article Hero */
        .article-hero {
            position: relative;
            height: 70vh;
            min-height: 500px;
            max-height: 700px;
            overflow: hidden;
        }

        .article-hero img {
            width: 100%;
            height: 100%;
            object-fit: cover;
        }

        .article-hero-overlay {
            position: absolute;
            inset: 0;
            background: linear-gradient(to top, rgba(0,0,0,0.8) 0%, rgba(0,0,0,0.3) 50%, rgba(0,0,0,0.1) 100%);
        }

        .article-hero-content {
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            padding: 4rem;
            max-width: 900px;
            margin: 0 auto;
            text-align: center;
        }

        .article-tag {
            display: inline-block;
            background: var(--wgac-blue);
            color: white;
            padding: 0.35rem 0.75rem;
            font-weight: 700;
            font-size: 0.65rem;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 1.5rem;
        }

        .article-hero h1 {
            font-family: var(--font-display);
            font-size: clamp(2.5rem, 5vw, 3.5rem);
            font-weight: 400;
            line-height: 1.15;
            color: white;
            margin-bottom: 1.5rem;
        }

        .article-meta {
            color: rgba(255,255,255,0.7);
            font-size: 0.9rem;
        }

        .article-meta span { margin: 0 0.75rem; }

        /* Article Content */
        .article-content {
            max-width: 700px;
            margin: 0 auto;
            padding: 4rem 2rem;
        }

        .article-lead {
            font-size: 1.35rem;
            line-height: 1.7;
            color: var(--dark);
            margin-bottom: 2rem;
            font-weight: 400;
        }

        .article-body p {
            font-size: 1.1rem;
            line-height: 1.8;
            margin-bottom: 1.5rem;
            color: var(--gray-600);
        }

        .article-body h2 {
            font-family: var(--font-display);
            font-size: 1.75rem;
            margin: 3rem 0 1.5rem;
            color: var(--dark);
        }

        .article-body blockquote {
            border-left: 3px solid var(--wgac-blue);
            padding-left: 1.5rem;
            margin: 2rem 0;
            font-family: var(--font-display);
            font-size: 1.4rem;
            font-style: italic;
            color: var(--dark);
        }

        /* Stats Box */
        .stats-box {
            background: var(--wgac-blue);
            color: white;
            padding: 2.5rem;
            margin: 3rem 0;
        }

        .stats-box h3 {
            font-family: var(--font-display);
            font-size: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .stat-item { text-align: center; }

        .stat-number {
            font-family: var(--font-display);
            font-size: 3rem;
            line-height: 1;
            margin-bottom: 0.5rem;
        }

        .stat-label {
            font-size: 0.8rem;
            opacity: 0.9;
        }

        /* Image with caption */
        .article-figure {
            margin: 3rem -4rem;
        }

        .article-figure img {
            width: 100%;
            display: block;
        }

        .article-figure figcaption {
            font-size: 0.85rem;
            color: var(--gray-400);
            padding: 1rem 4rem;
            text-align: center;
        }

        .sources-box {
            margin-top: 3rem;
            padding: 2rem;
            background: var(--gray-100);
            border-left: 4px solid var(--wgac-blue);
        }

        .sources-box h3 {
            font-family: var(--font-body);
            font-size: 0.8rem;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: var(--gray-600);
            margin-bottom: 1rem;
        }

        .sources-box ul {
            list-style: none;
        }

        .sources-box li {
            margin-bottom: 0.5rem;
        }

        .sources-box a {
            color: var(--wgac-blue);
            font-size: 0.9rem;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: border-color 0.2s ease;
        }

        .sources-box a:hover {
            border-bottom-color: var(--wgac-blue);
        }

        /* Related Articles */
        .related-section {
            background: var(--gray-100);
            padding: 4rem 2rem;
            margin-top: 4rem;
        }

        .related-inner {
            max-width: 1200px;
            margin: 0 auto;
        }

        .related-title {
            font-family: var(--font-display);
            font-size: 1.5rem;
            margin-bottom: 2rem;
            padding-bottom: 1rem;
            border-bottom: 2px solid var(--dark);
        }

        .related-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .related-card {
            background: white;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .related-card:hover { background: var(--cream); }
        .related-card:hover h4 { color: var(--wgac-brown); }

        .related-card img {
            width: 100%;
            height: 180px;
            object-fit: cover;
            display: block;
        }

        .related-card-content {
            padding: 1.25rem;
        }

        .related-card h4 {
            font-family: var(--font-display);
            font-size: 1.1rem;
            line-height: 1.35;
            transition: color 0.2s ease;
        }

        /* Footer */
        .site-footer {
            background: var(--dark);
            color: white;
            padding: 4rem 3rem;
        }

        .footer-content {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
        }

        .footer-brand {
            max-width: 350px;
        }

        .footer-logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 0.85rem;
            font-weight: 800;
            margin-bottom: 1rem;
            width: fit-content;
        }

        .footer-logo .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.4rem 0.6rem;
        }

        .footer-logo .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.4rem 0.6rem;
        }

        .footer-tagline {
            font-size: 0.9rem;
            color: var(--gray-400);
            line-height: 1.6;
        }

        .footer-nav {
            display: flex;
            gap: 4rem;
        }

        .footer-col h4 {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 1px;
            text-transform: uppercase;
            color: var(--gray-400);
            margin-bottom: 1rem;
        }

        .footer-col ul {
            list-style: none;
        }

        .footer-col li {
            margin-bottom: 0.5rem;
        }

        .footer-col a {
            font-size: 0.9rem;
            color: white;
            opacity: 0.8;
            transition: opacity 0.2s ease;
        }

        .footer-col a:hover {
            opacity: 1;
        }

        .footer-bottom {
            max-width: 1400px;
            margin: 3rem auto 0;
            padding-top: 2rem;
            border-top: 1px solid rgba(255,255,255,0.1);
            font-size: 0.8rem;
            color: var(--gray-400);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .footer-update {
            font-size: 0.7rem;
            opacity: 0.6;
            letter-spacing: 0.5px;
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .related-grid {
                grid-template-columns: 1fr;
            }
            .footer-content {
                flex-direction: column;
                gap: 3rem;
            }
        }

        @media (max-width: 768px) {
            .header-top { padding: 1rem 1.5rem; }
            .main-nav { flex-wrap: wrap; }
            .nav-link { padding: 0.75rem 1rem; font-size: 0.7rem; }
            .article-hero-content { padding: 2rem 1.5rem; }
            .article-content { padding: 2rem 1.5rem; }
            .article-figure { margin: 2rem -1.5rem; }
            .article-figure figcaption { padding: 1rem 1.5rem; }
            .stats-grid { grid-template-columns: 1fr; gap: 1.5rem; }
        }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="site-header">
        <div class="header-top">
            <a href="../index.html" class="logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></a>
            <div class="header-date">Wednesday, January 29, 2026</div>
        </div>
        <nav class="main-nav">
            <a href="../index.html" class="nav-link">Today</a>
            <a href="../climate.html" class="nav-link">Climate</a>
            <a href="../health.html" class="nav-link">Health</a>
            <a href="../science.html" class="nav-link active">Science</a>
            <a href="../people.html" class="nav-link">People</a>
            <a href="../wildlife.html" class="nav-link">Wildlife</a>
            <a href="../cats.html" class="nav-link">Cats</a>
        </nav>
    </header>

    <!-- Article Hero -->
    <div class="article-hero">
        <img src="https://images.unsplash.com/photo-1530026405186-ed1f139313f8?w=1920&q=80" alt="Baby taking first steps">
        <div class="article-hero-overlay"></div>
        <div class="article-hero-content">
            <span class="article-tag">Science</span>
            <h1>Baby KJ: World's First Personalized CRISPR Gene Therapy Success</h1>
            <div class="article-meta">
                <span>By Gene Splice</span>
                <span>-</span>
                <span>January 29, 2026</span>
                <span>-</span>
                <span>5 min read</span>
            </div>
        </div>
    </div>

    <!-- Article Content -->
    <article class="article-content">
        <p class="article-lead">
            KJ Muldoon was born with CPS1 deficiency, a rare metabolic disorder that causes toxic ammonia to build up in the blood. About 50% of infants with the severe form die in infancy. In February 2025, he became the first person ever to receive a personalized CRISPR gene-editing therapy. Now he's home and thriving.
        </p>

        <div class="article-body">
            <p>
                Sometimes science delivers miracles. On June 2, 2025, after 307 days at Children's Hospital of Philadelphia (CHOP), KJ Muldoon went home. He was the first patient in history to be treated with a gene therapy designed specifically for his unique genetic mutation. And it worked.
            </p>

            <p>
                KJ was born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare urea cycle disorder affecting approximately 1 in 1.3 million people worldwide. His body couldn't process protein properly, causing ammonia to accumulate to dangerous levels. When doctors first tested his blood, his ammonia levels exceeded 1,000 micromol/L - far above the normal range of 9-33.
            </p>

            <blockquote>
                "This case represents a blueprint for how we might approach rare genetic diseases in the future. Truly personalized medicine is now possible."
            </blockquote>

            <p>
                That assessment comes from researchers involved in KJ's treatment. The therapy was developed in a remarkable six months after KJ's birth - an unprecedented timeline for what is essentially a custom-built medicine.
            </p>

            <div class="stats-box">
                <h3>KJ's Journey</h3>
                <div class="stats-grid">
                    <div class="stat-item">
                        <div class="stat-number">6</div>
                        <div class="stat-label">Months to develop personalized therapy</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">307</div>
                        <div class="stat-label">Days in hospital before going home</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">1st</div>
                        <div class="stat-label">Patient ever treated with personalized CRISPR</div>
                    </div>
                </div>
            </div>

            <h2>The Treatment That Changed Everything</h2>

            <p>
                Researchers discovered that KJ had two specific CPS1 mutations - Q335X inherited from his father and E714X inherited from his mother. Dr. Rebecca Ahrens-Nicklas at CHOP and Dr. Kiran Musunuru at Penn Medicine designed a base editing therapy specifically targeting KJ's variant.
            </p>

            <p>
                They named the therapy "kayjayguran abengcemeran" (or "k-abe" after KJ). It uses lipid nanoparticles to deliver the base editor to liver cells, where it corrects the faulty gene. Unlike traditional gene therapy, base editing doesn't cut the DNA - it chemically converts one letter of the genetic code to another, like a molecular spell-checker.
            </p>

            <p>
                KJ received his first infusion on February 25, 2025, when he was six months old. He received follow-up doses in March and April 2025. The results were dramatic: his ammonia levels stabilized, he began tolerating increased dietary protein, and he needed less of the medication that had been keeping him alive.
            </p>

            <figure class="article-figure">
                <img src="https://images.unsplash.com/photo-1576086213369-97a306d36557?w=1400&q=80" alt="DNA helix illustration">
                <figcaption>Base editing technology allows scientists to correct genetic mutations without cutting DNA. Photo: National Institutes of Health</figcaption>
            </figure>

            <h2>What This Means for the Future</h2>

            <p>
                KJ's case demonstrates something profound: with modern base-editing technology, lipid-nanoparticle delivery, and rapid development pipelines, truly personalized single-patient therapies are now feasible. The treatment transformed his severe, neonatal-onset metabolic disorder into a much milder form of the disease.
            </p>

            <p>
                Researchers involved in the case speak of this treatment as a "blueprint" for similar bespoke therapies that could be tailored rapidly for other rare metabolic or genetic diseases. There are thousands of such conditions, many affecting only a handful of patients worldwide.
            </p>

            <p>
                KJ Muldoon has been recognized in Nature's 10, the prestigious list of people who shaped science in 2025. But for his family, the significance is simpler: they have a son who was supposed to die. He didn't. He's home.
            </p>

            <h2>A New Era of Medicine</h2>

            <p>
                The implications extend far beyond KJ's specific condition. The speed at which his therapy was developed - six months from diagnosis to first treatment - suggests a future where genetic diseases might be addressed almost as soon as they're identified.
            </p>

            <p>
                "We're not just treating diseases anymore," the research team noted. "We're correcting the underlying genetic errors so the disease never fully develops. That's a fundamentally different kind of medicine."
            </p>

            <p>
                For a baby who spent his first 307 days in the hospital, the future now stretches out wide and full of possibility. KJ Muldoon is alive because scientists built a treatment that had never existed before, specifically for him. That's what personalized medicine looks like.
            </p>

            <div class="sources-box">
                <h3>Sources</h3>
                <ul>
                    <li><a href="https://www.chop.edu/news/worlds-first-patient-treated-personalized-crispr-gene-editing-therapy-childrens-hospital" target="_blank">CHOP: World's First Patient Treated with Personalized CRISPR</a></li>
                    <li><a href="https://www.nature.com/articles/d41586-025-03847-2" target="_blank">Nature: The Baby Whose Life Was Saved by the First Personalized CRISPR Therapy</a></li>
                    <li><a href="https://penntoday.upenn.edu/news/penn-medicine-worlds-first-patient-treated-personalized-crispr-gene-editing-therapy-childrens-hospital" target="_blank">Penn Today: Penn Medicine Collaboration on First Personalized CRISPR Therapy</a></li>
                    <li><a href="https://en.wikipedia.org/wiki/KJ_Muldoon" target="_blank">Wikipedia: KJ Muldoon</a></li>
                </ul>
            </div>
        </div>
    </article>

    <!-- Related Articles -->
    <section class="related-section">
        <div class="related-inner">
            <h2 class="related-title">More Science Stories</h2>
            <div class="related-grid">
                <a href="huntingtons-gene-therapy.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1532094349884-543bc11b234d?w=600&q=80" alt="Laboratory">
                    <div class="related-card-content">
                        <h4>AMT-130 Gene Therapy Slows Huntington's By 75%</h4>
                    </div>
                </a>
                <a href="mrna-cancer.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1631549916768-4119b2e5f926?w=600&q=80" alt="Cancer research">
                    <div class="related-card-content">
                        <h4>mRNA Cancer Vaccines Show Promise</h4>
                    </div>
                </a>
                <a href="blindness-treatment.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1579684385127-1ef15d508118?w=600&q=80" alt="Medical research">
                    <div class="related-card-content">
                        <h4>Gene Therapy Gives Blind Children Sight</h4>
                    </div>
                </a>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer">
        <div class="footer-content">
            <div class="footer-brand">
                <div class="footer-logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></div>
                <p class="footer-tagline">Doom-scrolling is so last decade. We bring you the breakthroughs, the victories, and the genuinely good stuff happening in the world.</p>
            </div>
            <nav class="footer-nav">
                <div class="footer-col">
                    <h4>Sections</h4>
                    <ul>
                        <li><a href="../climate.html">Climate</a></li>
                        <li><a href="../health.html">Health</a></li>
                        <li><a href="../science.html">Science</a></li>
                        <li><a href="../people.html">People</a></li>
                        <li><a href="../wildlife.html">Wildlife</a></li>
                        <li><a href="../cats.html">Cats</a></li>
                    </ul>
                </div>
                <div class="footer-col">
                    <h4>About</h4>
                    <ul>
                        <li><a href="../mission.html">Our Mission</a></li>
                        <li><a href="../team.html">Team</a></li>
                        <li><a href="../contact.html">Contact</a></li>
                    </ul>
                </div>
            </nav>
        </div>
        <div class="footer-bottom">
            <span>2026 News That's Not Crap. All the good vibes reserved.</span>
            <span class="footer-update">Updated daily at 6am Eastern</span>
        </div>
    </footer>
</body>
</html>
